Results 51 to 60 of about 19,439,562 (313)

Measurement of pacemaker performance [PDF]

American Heart Journal, 1966
Abstract Entirely satisfactory treatment of complete heart block has been prevented by an inability to measure pacemaker function after implantation. Two major problems can be identified in the long-term management of pacemaker patients: first, adequate prediction of when a pacemaker will fail; and second, accurate diagnosis of the type of pacemaker ...
Preston, Thomas A., Judge, Richard D., Bowers, David L., Morris, Joe D.   +3 more
openaire   +3 more sources

Deep Sequencing of FLT3‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm, Bea Tornberg, Erik Delsing Malmberg, Henrik Hasle, Kristian Løvvik Juul‐Dam, Lars Palmqvist, Borhan R. Saeed, Giti Shah Barkhordar, Anastasia Soboli, Anna Staffas, Jonas Abrahamsson, Linda Fogelstrand   +11 more
wiley   +1 more source

Performance measures in evaluating machine learning based bioinformatics predictors for classifications

Quantitative Biology, 2016
BackgroundMany existing bioinformatics predictors are based on machine learning technology. When applying these predictors in practical studies, their predictive performances should be well understood.
Yasen Jiao, Pufeng Du
semanticscholar   +1 more source

Measuring performance in the NHS

BMJ, 1998
Last Wednesday the government launched its consultation paper on assessing performance,1 the latest element of its strategy to reform the NHS.2 It proposes moving from a narrow focus on activity and financial targets to a wider view of what the NHS is seeking to achieve and suggests a framework for achieving it.
M, McKee, T, Sheldon
openaire   +3 more sources

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke, Christian Thomas, Michael C. Frühwald, Pascal D. Johann, Martin Hasselblatt   +4 more
wiley   +1 more source

Measuring Scorecard Performance [PDF]

, 2004
In this paper, we look at ways to measure the classification performance of a scoring system and the overall characteristics of a scorecard. We stick to the idea that we will measure the scoring system by how well it classifies, which are still problems in measuring its performance.
Zheng Yang, Yue Wang, Yu Bai, Xin Zhang
openaire   +1 more source

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook, Veerain Gupta, Nicholas J. Clark, Vijay Rings, Lauren E. Corona, Douglass B. Clayton, Daniel J. Benedetti   +6 more
wiley   +1 more source

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási, Bernadett Borbála Huszti, Gábor Barna, Marko Kavcic, Janez Jazbec, Lennart Lenk, Vera Münch, Sophia Polychronopoulou, Ágnes Márk, Maria Thastrup, Lüder H. Meyer, Kjeld Schmiegelow, Cornelia Eckert, Christina Halsey, Dániel J. Erdélyi   +14 more
wiley   +1 more source

The Intellectual Capital Performance Of Banks Within Gulf Cooperative Council (GCC) Countries: An Application Of VAIC TM1 Model [PDF]

المجلة العلمية للاقتصاد والتجارة, 2015
The paper uses the Value Added Intellectual Coefficient VAICTM model, a widely used model to measure the Intellectual Capital efficiency of the banks within Gulf cooperation Council (GCC) using a 5  years period data set from 2007 to 2011.
Hameed Al-Qaheri, Ridha Al-Khayyat, Fayez Abdulsalam   +2 more
doaj   +1 more source

Measurement Of Innovation Performance

, 2014
Time full of changes which is associated with globalization, tougher competition, changes in the structures of markets and economic downturn, that all force companies to think about their competitive advantages. These changes can bring the company a competitive advantage and that can help improve competitive position in the market.
M. Chobotová, Ž. Rylková
openaire   +4 more sources